These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2168132)

  • 1. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB; Behrendt W; Stein T
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of endoxin in hypertensive patients].
    Gorjão Clara J; Breitenfeld B; Bicho M; Moreira C; Carvalho C; Boaventura I; Manso C; Nogueira da Costa J
    Rev Port Cardiol; 1991 Jan; 10(1):29-33. PubMed ID: 1647807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous digoxin-like immunoreactive factor].
    Rispler S; Jakobi P; Krivoy N
    Harefuah; 1990 Jul; 119(1-2):36-8. PubMed ID: 2172126
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in serum endogenous digoxin-like substances in cirrhotic patients treated by ultrafiltration of ascites and reinfusion].
    Yang J
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):329-30. PubMed ID: 1667498
    [No Abstract]   [Full Text] [Related]  

  • 9. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous digoxin-like immunoreactive factor is elevated in advanced chronic respiratory failure.
    Varsano S; Shilo L; Bruderman I; Dolev S; Shenkman L
    Chest; 1992 Jan; 101(1):146-9. PubMed ID: 1309496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endogenous digoxin-like factor: serum concentration and interrelations with the electrolyte picture in normal subjects].
    Andronico G; Mangano MT; Carone MB; Cerasola G
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1053-8. PubMed ID: 2560923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the activity of Na+ K+ ATPase in erythrocytes and immunoreactive plasma digoxin-like substances in chronic renal insufficiency: their relation to blood pressure levels].
    Widimský J; Horký K; Lachmanová J; Dvoráková J
    Vnitr Lek; 1988 Sep; 34(9):843-50. PubMed ID: 2849244
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.
    Clerico A
    J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased concentrations of a circulating sodium pump inhibitor in essential hypertension and uraemia and its partial purification from haemofiltrate.
    Wenzel M; Heidrich E; Kirch U; Moreth-Wolfrat K; Wizemann V; Schoner W
    Physiol Bohemoslov; 1990; 39(1):79-85. PubMed ID: 2165269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
    Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
    Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiological and physiopathological significance of endogenous digitalis-like factor in hypertension].
    Shibata H; Kojima I
    Nihon Rinsho; 1992 Apr; 50 Suppl():382-8. PubMed ID: 1321920
    [No Abstract]   [Full Text] [Related]  

  • 17. Digoxin-like immunoreactivity in human body fluids.
    Clerico A; Del Chicca MG; Montereggi A; Balzan S; Ghione S
    J Nucl Med Allied Sci; 1985; 29(4):305-12. PubMed ID: 3012031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endogenous digitalis-like substances].
    Zhu DL
    Sheng Li Ke Xue Jin Zhan; 1986 Oct; 17(4):333-7. PubMed ID: 3026044
    [No Abstract]   [Full Text] [Related]  

  • 19. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous digitalis-like factors. Present state].
    Schreiber V; Kölbel F; Stĕpán J
    Cas Lek Cesk; 1988 Jul; 127(30):929-31. PubMed ID: 2844408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.